With the rapid development of science and technology, many people have begun to have new expectations for eternal life. In recent years, an emerging industry is booming, and that is "cryonics." Rich people have frozen their bodies, hoping that future technology will allow them to be "resurrected". This new trend has also triggered a craze for "resurrection trusts", as wealthy people want to ensure that their properties can still cover the cost of resurrection a hundred years from now, which has also triggered legal and ethical controversies.
At present, the world's largest cryonics company "Alcor Life Extension Foundation" has more than 1,400 members, of which 230 people's bodies have been cryopreserved. The foundation said that the remains of more than 200 wealthy people have been frozen. Rich people usually sign contracts with cryonics companies and pay high fees to have their bodies frozen and preserved. In order to ensure that there are enough funds to pay for resurrection expenses in the future, they will set up a "resurrection trust" fund, and estate lawyers will help avoid inheritance taxes to ensure that the property can still maintain its value a hundred years later.
However, cryonics technology is still in the experimental stage, and whether resurrection can be achieved is still largely unknown. Estate lawyer House said: "When clients create these trusts, the only beneficiary is themselves after resurrection. If the death certificate is to be overturned, it may cause legal problems."
Additionally, there are legal limits on how long a trust can last. Billup, the trust's legal advisor, said: "Some states have begun to relax relevant regulations to attract more trust funds to the place." Heritage research scholar Hahnemann believes: "Resurrection trusts should have clear regulations. If scientists find that it is impossible, When resurrecting the frozen dead, the relevant funds will be dealt with."
The 76-year-old Lebel is one of the advocates of cryonics technology. He said: "I believe that the aging process will be cured. Aging is a disease, but the current technology is not mature enough to cure the disease, but I can cure it through the human body." Cryogenics to extend my waiting time.”
The Guardian reported that the cost of freezing and preserving the whole body was US$220,000, and the cost of preserving only the nerves was US$80,000. This is an astronomical sum of money for most people. However, for the wealthy, it appears to be a worthy investment. They hope to have the opportunity to be "resurrected" when technology advances in the future.
The development of cryonics technology has caused many controversies. In addition to legal and ethical issues, there are also questions about whether the technology can actually achieve resurrection. The rich people's expectations for future technology and desire for resurrection also make people think about whether human beings' views on death are changing.
This is a piece of news of contemporary significance and topic, worthy of readers’ in-depth consideration.
The content of this article is for reference only and does not constitute investment advice or an invitation, solicitation or recommendation for any investment product. Readers are advised to make their own judgment and seek professional advice.
Any information on the 852Fin platform ("852Fin Information"), including but not limited to product comparisons, product ratings, blog articles, etc., is for general education and reference purposes only and does not constitute or intend to constitute any regulated advice, trust, immigration , insurance, finance, investment or other professional advice, recommendation, approval, endorsement, invitation, sale of insurance, trust, immigration, financial or investment products.
852FIN reminds readers that the content contained in this article/video is mainly from public information online and does not constitute any professional advice. Readers should seek professional advice with specific questions about products or services.
852Fin Information does not consider your personal needs, and reading the relevant information should not be regarded as a personal suitability assessment, nor can it form the basis for any decision to purchase products/services.
852FIN and the author of the pen column are not responsible for any loss or damage caused by the information contained or omitted in the article.
Before purchasing any product or service, you should conduct your own research based on the information provided by the company that provides you with the product or service, and/or seek independent and professional advice from a licensed professional. 852Fin information is collected, verified, and updated from different channels with our best efforts. 852Fin and its related parties, agents, directors, officers, and employees will not be held liable for any claims or losses arising from the relevant information. 852Fin also does not guarantee or guarantee the accuracy, completeness and timeliness of the relevant information.
Discussion about this post